Health care biotech companies by dividend yield
Dividends paid over the last twelve months as a share of today's price.
Amgen leads the 20 health care biotech companies ranked by dividend yield, at 2.24%, ahead of Gilead Sciences (1.92%) and Bio-Techne (0.33%). Figures as of 19 Nov 2026, 22:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Amgen2.24%
- Median
- 0.00%
- Combined market value
- SGD 1.07T
- Countries
- 5
- Not ranked
- 4no dividend yield on file
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Dividend yield ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | 2.24% | SGD 306.5B | SGD 566.63 | 1.14% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | 1.92% | SGD 266.7B | SGD 215.03 | 1.45% down | 35% up | ||
| 3 | Bio-TechneTECH · Health Care | 0.33% | SGD 14.7B | SGD 93.87 | 0.07% down | 24% up | ||
| 4 | ModernaMRNA · Health Care | 0.00% | SGD 104.1B | SGD 257.38 | 1.29% up | 780% up | ||
| 5 | BiogenBIIB · Health Care | 0.00% | SGD 47.2B | SGD 319.11 | 1.70% down | 49% up | ||
| 6 | Revolution MedicinesRVMD · Health Care | 0.00% | SGD 44.5B | SGD 205.86 | 0.24% down | 129% up | ||
| 7 | ExelixisEXEL · Health Care | 0.00% | SGD 20.7B | SGD 85.00 | 3.60% down | 63% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | 0.00% | SGD 20.5B | SGD 202.20 | 3.85% down | 17% up | ||
| 9 | RepligenRGEN · Health Care | 0.00% | SGD 14.1B | SGD 219.89 | 1.38% down | 12% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | 0.00% | SGD 13.7B | SGD 120.14 | 2.88% down | 39% up | ||
| 11 | Kymera TherapeuticsKYMR · Health Care | 0.00% | SGD 13.2B | SGD 154.16 | 1.44% down | 87% up | ||
| 12 | Krystal BiotechKRYS · Health Care | 0.00% | SGD 12.1B | SGD 407.80 | 0.15% up | 54% up | ||
| 13 | VaxcytePCVX · Health Care | 0.00% | SGD 11.9B | SGD 75.36 | 0.27% down | 23% up | ||
| 14 | Twist BioscienceTWST · Health Care | 0.00% | SGD 9.8B | SGD 144.13 | 4.07% down | 346% up | ||
| 15 | CG OncologyCGON · Health Care | 0.00% | SGD 9.4B | SGD 105.75 | 2.38% up | 97% up | ||
| 16 | ImmunityBioIBRX · Health Care | 0.00% | SGD 9B | SGD 8.48 | 1.94% down | 232% up | ||
| 17 | ImmunovantIMVT · Health Care | 0.00% | SGD 8.7B | SGD 41.99 | 1.96% down | 46% up | ||
| 18 | Kodiak SciencesKOD · Health Care | 0.00% | SGD 8.3B | SGD 126.41 | 0.09% up | 399% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | 0.00% | SGD 7.9B | SGD 65.04 | 4.94% up | 26% up | ||
| 20 | Adaptive BiotechnologiesADPT · Health Care | 0.00% | SGD 5.9B | SGD 36.22 | 1.44% down | 74% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2913 SGD). 4 companies have no dividend yield on file and are not ranked here.
Questions and answers
Which health care biotech companies rank first by dividend yield?
Amgen (2.24%), Gilead Sciences (1.92%) and Bio-Techne (0.33%) are the top three of the 20 health care biotech companies ranked by dividend yield as of 19 Nov 2026, 22:51 UTC.
How many health care biotech companies are in this ranking?
20 are ranked by dividend yield. 4 more have no dividend yield on file and are left out rather than ranked at zero.
What are these health care biotech companies worth together?
The 20 health care biotech companies ranked by dividend yield have a combined market value of SGD 1.07T as of 19 Nov 2026, 22:51 UTC.
What does ranking by dividend yield measure?
Dividends paid over the last twelve months as a share of today's price.
Learn how this ranking works
All markets guides →- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Health care biotech companies by dividend yield”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=dividend-yield
Underlying data: Yahoo Finance; SEC EDGAR.